3D printing of medical devices is an example of a manufacturing innovation, not a healthcare infrastructure innovation.

Increased patient satisfaction is not a direct benefit of telemedicine. However, telemedicine can lead to increased patient satisfaction by providing more convenient and accessible care.

The declining use of hospitals is not an emerging trend in healthcare infrastructure. In fact, the use of hospitals is expected to increase in the future due to the aging population and the increasing prevalence of chronic diseases.

High cost is not a challenge associated with the implementation of EHRs. In fact, EHRs can lead to cost savings in the long run by reducing the need for duplicate testing and improving efficiency.

Development of new drugs and therapies is not a potential benefit of AI in healthcare. AI can be used to improve the diagnosis and treatment of diseases, develop personalized medicine, and increase the efficiency of healthcare delivery, but it cannot be used to develop new drugs and therapies.

The demand for more patient-centered care is not a key factor driving the rise of value-based care. In fact, value-based care is a patient-centered approach to healthcare that focuses on delivering high-quality care at a lower cost.

Increased patient satisfaction is not a potential challenge associated with the increasing use of telehealth. In fact, telehealth can lead to increased patient satisfaction by providing more convenient and accessible care.

Development of new drugs and therapies is not a potential benefit of the use of AI in healthcare. AI can be used to improve the diagnosis and treatment of diseases, develop personalized medicine, and increase the efficiency of healthcare delivery, but it cannot be used to develop new drugs and therapies.

The demand for more patient-centered care is not a key factor driving the rise of value-based care. In fact, value-based care is a patient-centered approach to healthcare that focuses on delivering high-quality care at a lower cost.

Increased patient satisfaction is not a potential challenge associated with the increasing use of telehealth. In fact, telehealth can lead to increased patient satisfaction by providing more convenient and accessible care.

Development of new drugs and therapies is not a potential benefit of the use of AI in healthcare. AI can be used to improve the diagnosis and treatment of diseases, develop personalized medicine, and increase the efficiency of healthcare delivery, but it cannot be used to develop new drugs and therapies.

The demand for more patient-centered care is not a key factor driving the rise of value-based care. In fact, value-based care is a patient-centered approach to healthcare that focuses on delivering high-quality care at a lower cost.

Increased patient satisfaction is not a potential challenge associated with the increasing use of telehealth. In fact, telehealth can lead to increased patient satisfaction by providing more convenient and accessible care.

Development of new drugs and therapies is not a potential benefit of the use of AI in healthcare. AI can be used to improve the diagnosis and treatment of diseases, develop personalized medicine, and increase the efficiency of healthcare delivery, but it cannot be used to develop new drugs and therapies.

The demand for more patient-centered care is not a key factor driving the rise of value-based care. In fact, value-based care is a patient-centered approach to healthcare that focuses on delivering high-quality care at a lower cost.